KZA 0.00% 8.0¢ kazia therapeutics limited

Value of Cantrixil, page-9

  1. 20,920 Posts.
    lightbulb Created with Sketch. 875
    RBX


    Genentech sold GDC0084 with a licence agreement in 2016

    Genentech has not had to worry about ongoing expenditure for2016, 2017,2018,2019 etc

    Genentech has received an upfront payment of $5m plus other entitlements - milestone payments as per licence agreement

    Genentech does not need worry about upwards of $20m for phase 11b trial and imo will receive a milestone payment if phase 11b commences

    Genentech does not need to hit the market for capital for GDC0084

    DYOR all above fair and realistic debating points
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.